These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 9556464)
1. Aspirin use and colorectal cancer: post-trial follow-up data from the Physicians' Health Study. Stürmer T; Glynn RJ; Lee IM; Manson JE; Buring JE; Hennekens CH Ann Intern Med; 1998 May; 128(9):713-20. PubMed ID: 9556464 [TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer after start of nonsteroidal anti-inflammatory drug use. Stürmer T; Buring JE; Lee IM; Kurth T; Gaziano JM; Glynn RJ Am J Med; 2006 Jun; 119(6):494-502. PubMed ID: 16750963 [TBL] [Abstract][Full Text] [Related]
3. Aspirin use and risk of cataract in posttrial follow-up of Physicians' Health Study I. Christen WG; Ajani UA; Schaumberg DA; Glynn RJ; Manson JE; Hennekens CH Arch Ophthalmol; 2001 Mar; 119(3):405-12. PubMed ID: 11231774 [TBL] [Abstract][Full Text] [Related]
4. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. Chan AT; Giovannucci EL; Meyerhardt JA; Schernhammer ES; Curhan GC; Fuchs CS JAMA; 2005 Aug; 294(8):914-23. PubMed ID: 16118381 [TBL] [Abstract][Full Text] [Related]
5. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Flossmann E; Rothwell PM; Lancet; 2007 May; 369(9573):1603-13. PubMed ID: 17499602 [TBL] [Abstract][Full Text] [Related]
6. Low-dose aspirin and incidence of colorectal tumors in a randomized trial. Gann PH; Manson JE; Glynn RJ; Buring JE; Hennekens CH J Natl Cancer Inst; 1993 Aug; 85(15):1220-4. PubMed ID: 8331682 [TBL] [Abstract][Full Text] [Related]
7. A prospective study of aspirin use and the risk for colorectal adenoma. Chan AT; Giovannucci EL; Schernhammer ES; Colditz GA; Hunter DJ; Willett WC; Fuchs CS Ann Intern Med; 2004 Feb; 140(3):157-66. PubMed ID: 14757613 [TBL] [Abstract][Full Text] [Related]
8. Low-dose aspirin and risk of cataract and subtypes in a randomized trial of U.S. physicians. Christen WG; Manson JE; Glynn RJ; Ajani UA; Schaumberg DA; Sperduto RD; Buring JE; Hennekens CH Ophthalmic Epidemiol; 1998 Sep; 5(3):133-42. PubMed ID: 9805346 [TBL] [Abstract][Full Text] [Related]
9. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. Cole BF; Baron JA; Sandler RS; Haile RW; Ahnen DJ; Bresalier RS; McKeown-Eyssen G; Summers RW; Rothstein RI; Burke CA; Snover DC; Church TR; Allen JI; Robertson DJ; Beck GJ; Bond JH; Byers T; Mandel JS; Mott LA; Pearson LH; Barry EL; Rees JR; Marcon N; Saibil F; Ueland PM; Greenberg ER; JAMA; 2007 Jun; 297(21):2351-9. PubMed ID: 17551129 [TBL] [Abstract][Full Text] [Related]
10. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Giovannucci E; Rimm EB; Stampfer MJ; Colditz GA; Ascherio A; Willett WC Ann Intern Med; 1994 Aug; 121(4):241-6. PubMed ID: 8037405 [TBL] [Abstract][Full Text] [Related]
11. Regular Aspirin Use Associates With Lower Risk of Colorectal Cancers With Low Numbers of Tumor-Infiltrating Lymphocytes. Cao Y; Nishihara R; Qian ZR; Song M; Mima K; Inamura K; Nowak JA; Drew DA; Lochhead P; Nosho K; Morikawa T; Zhang X; Wu K; Wang M; Garrett WS; Giovannucci EL; Fuchs CS; Chan AT; Ogino S Gastroenterology; 2016 Nov; 151(5):879-892.e4. PubMed ID: 27475305 [TBL] [Abstract][Full Text] [Related]
12. Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial. Cook NR; Lee IM; Zhang SM; Moorthy MV; Buring JE Ann Intern Med; 2013 Jul; 159(2):77-85. PubMed ID: 23856681 [TBL] [Abstract][Full Text] [Related]
13. Aspirin and the prevention of colorectal cancer: a review of the evidence. Paganini-Hill A Semin Surg Oncol; 1994; 10(3):158-64. PubMed ID: 8085092 [TBL] [Abstract][Full Text] [Related]
14. Blood levels of long-chain polyunsaturated fatty acids, aspirin, and the risk of colorectal cancer. Hall MN; Campos H; Li H; Sesso HD; Stampfer MJ; Willett WC; Ma J Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):314-21. PubMed ID: 17301265 [TBL] [Abstract][Full Text] [Related]
15. Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drug Use and Colorectal Cancer Risk: A Population-Based, Case-Control Study. Friis S; Riis AH; Erichsen R; Baron JA; Sørensen HT Ann Intern Med; 2015 Sep; 163(5):347-55. PubMed ID: 26302241 [TBL] [Abstract][Full Text] [Related]
16. The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Dubé C; Rostom A; Lewin G; Tsertsvadze A; Barrowman N; Code C; Sampson M; Moher D; Ann Intern Med; 2007 Mar; 146(5):365-75. PubMed ID: 17339622 [TBL] [Abstract][Full Text] [Related]
17. The Protective Effect of Low-Dose Aspirin against Colorectal Cancer Is Unlikely Explained by Selection Bias: Results from Three Different Study Designs in Clinical Practice. Cea Soriano L; Soriano-Gabarró M; García Rodríguez LA PLoS One; 2016; 11(7):e0159179. PubMed ID: 27428004 [TBL] [Abstract][Full Text] [Related]
18. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. Sandler RS; Halabi S; Baron JA; Budinger S; Paskett E; Keresztes R; Petrelli N; Pipas JM; Karp DD; Loprinzi CL; Steinbach G; Schilsky R N Engl J Med; 2003 Mar; 348(10):883-90. PubMed ID: 12621132 [TBL] [Abstract][Full Text] [Related]
19. Aspirin dose and duration of use and risk of colorectal cancer in men. Chan AT; Giovannucci EL; Meyerhardt JA; Schernhammer ES; Wu K; Fuchs CS Gastroenterology; 2008 Jan; 134(1):21-8. PubMed ID: 18005960 [TBL] [Abstract][Full Text] [Related]
20. Folic acid and risk of prostate cancer: results from a randomized clinical trial. Figueiredo JC; Grau MV; Haile RW; Sandler RS; Summers RW; Bresalier RS; Burke CA; McKeown-Eyssen GE; Baron JA J Natl Cancer Inst; 2009 Mar; 101(6):432-5. PubMed ID: 19276452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]